trending Market Intelligence /marketintelligence/en/news-insights/trending/Si7YiJSbKz6yBqoyPvELBA2 content esgSubNav
In This List

Organovo to market tissue testing service in Japan

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Organovo to market tissue testing service in Japan

Organovo Holdings Inc. engaged Cosmo Bio Co. Ltd. to market and distribute its NovoView preclinical services in Japan.

The company will work with Cosmo's drug discovery services team to further its 3D bioprinting technology for testing kidney and liver tissue.